AI

Delve into the world of AI in China’s pharmaceutical industry. Fineline Info & Tech provides reliable data, news, and insights on AI to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

MindRank Signs Exclusive Greater China Commercialization Deal With Sunshine Mandi for MDR‑001 – AI‑Designed Oral GLP‑1 Candidate in Phase III for Obesity, Worth Up to RMB 1.75 Billion

MindRank announced an exclusive commercialization partnership with Sunshine Mandi Pharmaceutical, a subsidiary of 3SBio (HKG: 1530), for MDR‑001 — an AI‑designed, oral small‑molecule GLP‑1 receptor agonist independently developed by MindRank.…

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.